🇺🇸 FDA
Patent

US 9580428

Compositions and methods for inhibiting viral polymerase

granted A61KA61K31/519A61K9/0019

Quick answer

US patent 9580428 (Compositions and methods for inhibiting viral polymerase) held by BioCryst Pharmaceuticals, Inc. expires Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BioCryst Pharmaceuticals, Inc.
Grant date
Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/519, A61K9/0019, A61K9/0053, A61K9/12